Longchamp Gregoire, Abbassi Ziad, Meyer Jeremy, Toso Christian, Buchs Nicolas C, Ris Frederic
Division of Digestive Surgery, University Hospitals of Geneva, Rue Gabrielle-PerreT-Gentil 4, 1211, Geneva, Switzerland.
Int J Colorectal Dis. 2021 Feb;36(2):227-237. doi: 10.1007/s00384-020-03762-0. Epub 2020 Sep 28.
Fifteen percent of patients undergoing elective sigmoidectomy will present a diverticulitis recurrence, which is associated with significant costs and morbidity. We aimed to systematically review the risk factors associated with recurrence after elective sigmoidectomy.
PubMed/MEDLINE, Embase, Cochrane, and Web of Science were searched for studies published until May 1, 2020. Original studies were included if (i) they included patients undergoing sigmoidectomy for diverticular disease, (ii) they reported postoperative recurrent diverticulitis, and (iii) they analyzed ≥ 1 variable associated with recurrence. The primary outcome was the risk factors for recurrence of diverticulitis after sigmoidectomy.
From the 1463 studies initially screened, six studies were included. From the 1062 patients included, 62 patients recurred (5.8%), and six variables were associated with recurrence. Two were preoperative: age (HR = 0.96, p = 0.02) and irritable bowel syndrome (33.3% with recurrence versus 12.1% without recurrence, p = 0.02). Two were operative factors: uncomplicated recurrent diverticulitis as indication for surgery (73.3% with recurrence versus 49.9% without recurrence, p = 0.049) and anastomotic level (colorectal: HR = 11.4, p = 0.02, or colosigmoid: OR = 4, p = 0.033). Two were postoperative variables: the absence of active diverticulitis on pathology (39.6% with recurrence versus 26.6% without recurrence) and persistence of postoperative pain (HR = 4.8, p < 0.01).
Identification of preoperative variables that predict the occurrence of diverticulitis recurrence should help surgical decision-making for elective sigmoidectomy, while peri- and postoperative factors should be taken into account for optimal patient follow-up.
接受择期乙状结肠切除术的患者中有15%会出现憩室炎复发,这与高昂的费用和发病率相关。我们旨在系统回顾择期乙状结肠切除术后复发的相关危险因素。
检索了PubMed/MEDLINE、Embase、Cochrane和Web of Science数据库中截至2020年5月1日发表的研究。纳入的原始研究需满足以下条件:(i)研究对象为因憩室病接受乙状结肠切除术的患者;(ii)报告了术后复发性憩室炎;(iii)分析了≥1个与复发相关的变量。主要结局是乙状结肠切除术后憩室炎复发的危险因素。
在最初筛选的1463项研究中,纳入了6项研究。在纳入的1062例患者中,62例复发(5.8%),6个变量与复发相关。两个是术前因素:年龄(HR = 0.96,p = 0.02)和肠易激综合征(复发率为33.3%,未复发率为12.1%,p = 0.02)。两个是手术因素:以非复杂性复发性憩室炎作为手术指征(复发率为73.3%,未复发率为49.9%,p = 0.049)和吻合水平(结直肠吻合:HR = 11.4,p = 0.02,或结肠乙状结肠吻合:OR = 4,p = 0.033)。两个是术后变量:病理检查无活动性憩室炎(复发率为39.6%,未复发率为26.6%)和术后疼痛持续存在(HR = 4.8,p < 0.01)。
识别预测憩室炎复发的术前变量应有助于择期乙状结肠切除术的手术决策,而围手术期和术后因素应在对患者进行最佳随访时予以考虑。